Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug 2:3:233.
doi: 10.3389/fimmu.2012.00233. eCollection 2012.

Dendritic cells a double-edge sword in autoimmune responses

Affiliations

Dendritic cells a double-edge sword in autoimmune responses

Giada Amodio et al. Front Immunol. .

Abstract

Dendritic cells (DC) are antigen-presenting cells that play a pivotal role in regulating innate and adaptive immune responses. In autoimmunity, DC act as a double-edged sword since on one hand they initiate adaptive self-reactive responses and on the other they play a pivotal role in promoting and maintaining tolerance. Thus, DC are the most important cells in either triggering self-specific responses or in negatively regulating auto-reactive responses. The latter function is mediated by DC in the steady-state or specialized subsets of DC, named tolerogenic DC. Clinical and experimental evidence indicate that prolonged presentation of self-antigens by DC is crucial for the development of destructive autoimmune diseases, and defects in tolerogenic DC functions contribute to eradication of self-tolerance. In recent years, DC have emerged as therapeutic targets for limiting their immunogenicity against self-antigens, while tolerogenic DC have been conceived as therapeutic tools to restore tolerance. The purpose of this review is to give a general overview of the current knowledge on the pathogenic role of DC in patients affected by autoimmune diseases. In addition, the protective role of tolerogenic DC will be addressed. The currently applied strategies to block immune activation or to exploit the tolerogenic potential of DC will be discussed.

Keywords: autoimmune diseases; dendritic cells; tolerance.

PubMed Disclaimer

References

    1. Banchereau J., Steinman R. M. (1998). Dendritic cells and the control of immunity. Nature 392 245–252 - PubMed
    1. Baumgart D. C., Metzke D., Guckelberger O., Pascher A., Grotzinger C., Przesdzing I., Dorffel Y., Schmitz J., Thomas S. (2011). Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn’s disease and ulcerative colitis. Clin. Exp. Immunol. 166 46–54 - PMC - PubMed
    1. Begue B., Verdier J., Rieux-Laucat F., Goulet O., Morali A., Canioni D., Hugot J. P., Daussy C., Verkarre V., Pigneur B., Fischer A., Klein C., Cerf-Bensussan N., Ruemmele F. M. (2011). Defective IL10 signaling defining a subgroup of patients with inflammatory bowel disease. Am. J. Gastroenterol. 106 1544–1555 - PubMed
    1. Belz G. T., Nutt S. L. (2012). Transcriptional programming of the dendritic cell network. Nat. Rev. Immunol. 12 101–113 - PubMed
    1. Boks M. A., Kager-Groenland J. R., Haasjes M. S., Zwaginga J. J., Van Ham S. M, Ten Brinke A. (2012). IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction – a comparative study of human clinical-applicable DC. Clin. Immunol. 142 332–342 - PubMed

LinkOut - more resources